Immunology
Latest News
Anaphylaxis Treatment Uncertainty Persists for Patients and Professionals
Many patients and families struggle to recognize and manage severe allergic reactions effectively.
Opinion
Just Call It ‘Chronic Rhinitis’ and Reach for These Treatments
One clue that it might be nonallergic rhinitis is the age of onset. If the symptoms are later in onset (older age), then 30%-40% of rhinitis is...
Latest News
PCPs Play a Key Role in Managing and Preventing the Atopic March in Children
“The most important thing PCPs can do is know that the atopic march exists, how it progresses over time, and what signs and symptoms to look for...
Latest News
Nobel Prize in Medicine Awarded to MicroRNA Researchers
Dr. Victor Ambros and Dr. Gary Ruvkun won the Nobel Prize in medicine for their discovery of microRNAs.
News from the FDA/CDC
FDA Approves Ustekinumab Biosimilar Otulfi
This is the fourth ustekinumab biosimilar approved in the United States.
From the Journals
New Biologic Tulisokibart Beats Placebo in Ulcerative Colitis Trial
Researchers said this was the first rigorous study of a drug class with an entirely new mechanism of action that may be beneficial in other immune...
From the Journals
Environmental Pollutants Play a Growing Role in IBD
Heavy and transition metals were associated with gut dysbiosis and overgrowth of undesirable species of microorganisms.
Myth of the Month
Myth of the Month: Vitamin C vs the Common Cold
While vitamin C is safe, there is no evidence for its ability to prevent the common cold.
Latest News
The New Formula for Stronger, Longer-Lasting Vaccines
Stanford researchers have developed a new vaccine helper that combines two kinds of adjuvants.
Latest News
Celiac Disease: Five Things to Know
Although avoidance of gluten is key to preventing villous atrophy, it is challenging and may not resolve all clinical issues.
Latest News
New Administration Routes for Adrenaline in Anaphylaxis
Intramuscular autoinjectors are not always used for a variety of reasons; new administration routes may increase use.